Multipharma
ActiveSummary
Multipharma has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €128.1m and a net result of -€2.9m. Equity is growing by ~4.3% per year across the filed fiscal years. Its solvency ranks better than 61% of 4913 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
History
Acts, filings and financial milestones
23-06
State Gazette act
Resignation: Delphine HAHAJI (member of the executive committee)10 facts ▸
- Board meeting, 11-06-2026
- Director resignation, Delphine HAHAJI (member of the executive committee)
- Board composition, Geert REYNIERS (member of the executive committee)
- Board composition, Jean MAGGIORDOMO (member of the executive committee)
- Board composition, Alain BOGAERT (member of the executive committee)
- Board composition, Peter DE GREEF (member of the executive committee)
- Board composition, Cindy DEWITTE (member of the executive committee)
- Board composition, Nicolas DELHAYE (member of the executive committee)
- Board composition, Quentin VAN BUYLAERE (member of the executive committee)
- Board composition, Patrick VAN GINNEKEN (member of the executive committee)
Show earlier events
About the unread acts
Of the 114 Belgian State Gazette acts we know for this company, 2 have been read. The other 112 have not been read yet: what they contain is neither established nor disproved here.